The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials
K Josan, SR Majumdar, FA McAlister - Cmaj, 2008 - Can Med Assoc
Background: Recent lipid guidelines recommend aggressive low-density lipoprotein (LDL)
cholesterol lowering in patients with coronary artery disease. To clarify the evidence for this …
cholesterol lowering in patients with coronary artery disease. To clarify the evidence for this …
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
CP Cannon, BA Steinberg, SA Murphy, JL Mega… - Journal of the American …, 2006 - jacc.org
Objectives: The purpose of this study was to conduct a meta-analysis that compares the
reduction of cardiovascular outcomes with high-dose statin therapy versus standard dosing …
reduction of cardiovascular outcomes with high-dose statin therapy versus standard dosing …
Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials
J Afilalo, AA Majdan, MJ Eisenberg - Heart, 2007 - heart.bmj.com
Background: Intensive statin therapy reduces major adverse cardiovascular events (MACE),
but the effect on mortality is unclear. Objective: To determine whether intensive statin …
but the effect on mortality is unclear. Objective: To determine whether intensive statin …
Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of> 40 000 patients
Aims Statin therapy is associated with important benefits for patients at risk of, and with,
established cardiovascular disease. There is widespread interest in whether intensive …
established cardiovascular disease. There is widespread interest in whether intensive …
Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: a systematic review and meta-analysis
YL Yan, B Qiu, LJ Hu, XD Jing, YJ Liu, SB Deng… - European journal of …, 2013 - Springer
Purpose To reveal and evaluate the efficacy and safety of intensive statin therapy in older
patients (age≥ 65 years) with coronary heart disease (CHD). Methods Electronic databases …
patients (age≥ 65 years) with coronary heart disease (CHD). Methods Electronic databases …
Treat-to-target or high-intensity statin in patients with coronary artery disease: a randomized clinical trial
SJ Hong, YJ Lee, SJ Lee, BK Hong, WC Kang, JY Lee… - Jama, 2023 - jamanetwork.com
Importance In patients with coronary artery disease, some guidelines recommend initial
statin treatment with high-intensity statins to achieve at least a 50% reduction in low-density …
statin treatment with high-intensity statins to achieve at least a 50% reduction in low-density …
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
CT Trialists - The Lancet, 2010 - thelancet.com
Background Lowering of LDL cholesterol with standard statin regimens reduces the risk of
occlusive vascular events in a wide range of individuals. We aimed to assess the safety and …
occlusive vascular events in a wide range of individuals. We aimed to assess the safety and …
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease
PS Chan, BK Nallamothu, HS Gurm, RA Hayward… - Circulation, 2007 - Am Heart Assoc
Background—Recent clinical trials found that high-dose statin therapy, compared with
conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with …
conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with …
Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
M Silva, ML Matthews, C Jarvis, NM Nolan… - Clinical …, 2007 - Elsevier
BACKGROUND:: Randomized trials evaluating intensive dose statin therapy have found
enhanced protection against cardiovascular (CV) events compared with moderate-dose …
enhanced protection against cardiovascular (CV) events compared with moderate-dose …
Relative safety profiles of high dose statin regimens
Recent clinical trials recommend achieving a low-density lipoprotein cholesterol level of<
100 mg/dl in high-risk and< 70 mg/dl in very high risk patients. To attain these goals …
100 mg/dl in high-risk and< 70 mg/dl in very high risk patients. To attain these goals …
Related searches
- meta analysis statin therapy
- efficacy and safety statin therapy
- meta analysis efficacy and safety
- artery disease statin therapy
- cardiovascular events statin therapy
- meta analysis ldl cholesterol
- older patients statin therapy
- incremental benefit statin therapy
- meta analysis cardiovascular events
- cost effectiveness statin therapy
- meta analysis heart disease
- meta analysis older patients
- efficacy and safety ldl cholesterol
- artery disease incremental benefit
- artery disease cost effectiveness
- safety profiles statin regimens